{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T17:40:06Z","timestamp":1750441206148,"version":"3.41.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Coronavirus disease 2019 infection produce a prothrombotic state. This is initiated through multiple pathways and is finally aggravated by cross talks with cytokine storm and neutrophil, platelet, complement activation. All these combine towards the second week of illness to produce thrombosis in the lung capillaries surrounding the alveolus producing characteristic pulmonary dysfunction (PaO<jats:sub>2<\/jats:sub>\/FiO<jats:sub>2<\/jats:sub>\u200a&gt;\u200a300, normal or minimally increased lung compliance and very high <jats:sc>d<\/jats:sc>-dimer levels) and a high rate of peripheral venous thrombosis. International and many national guidelines have approached this state in different ways but all emphasized the need for management and prevention of widespread thrombosis. It is felt more aggressive and graded thrombosis prevention and management should be initiated early in the treatment. <jats:sc>d<\/jats:sc>-Dimer, neutrophil count, SaO<jats:sub>2<\/jats:sub>, fibrinogen levels should be used to control the hypercoagulability. Drugs like statins which have anti-inflammatory action as well as ability to reduce fibrinogen and other clotting factors should be used in the beginning along with antiplatelet drugs and progressively complement activation and neutrophil extracellular traps inhibitors, oral mucopolysaccharides, full-scale anticoagulation along with judicial use of fibrinolysis supporting drugs should be added. In the present review, we have evaluated the various studies and argued the rationality that the anticoagulation in this condition should be initiated early during the infection and should be increased in a graded manner depending on clinical and laboratory progression of the condition until a strong specific antiviral drug for coronavirus disease 2019 infection is available.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mbc.0000000000000993","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T06:29:07Z","timestamp":1616221747000},"page":"167-171","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Thrombohaemorhhagic balance in coronavirus disease 2019 and its management: a perspective"],"prefix":"10.1097","volume":"32","author":[{"given":"Kanjaksha","family":"Ghosh","sequence":"first","affiliation":[{"name":"Thrombosis and Haemostasis Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malay","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Formerly Head of the Department of Haematology, Nil Ratan Sircar Medical College, Kolkata 7000'2, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,3,11]]},"reference":[{"key":"R1-20250620","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"R2-20250620","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"R3-20250620","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11239-020-02130-7","article-title":"Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia","volume":"50","author":"Pavoni","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"R4-20250620","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1111\/jth.14850","article-title":"Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis","volume":"18","author":"Panigada","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R5-20250620","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/bjh.16725","article-title":"Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis","volume":"189","author":"Xiong","year":"2020","journal-title":"Br J Haemat"},{"key":"R6-20250620","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jinf.2020.02.017","article-title":"Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2","volume":"80","author":"Xu","year":"2020","journal-title":"J Infect"},{"key":"R7-20250620","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1007\/s00330-020-06827-4","article-title":"The role of imaging in 2019 novel coronavirus pneumonia (COVID-19)","volume":"30","author":"Yang","year":"2020","journal-title":"Eur Radiol"},{"key":"R8-20250620","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1164\/rccm.202003-0817LE","article-title":"Covid-19 does not lead to a \u2018typical\u2019 acute respiratory distress syndrome","volume":"201","author":"Gattinoni","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"R9-20250620","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/CIRCULATIONAHA.120.046702","article-title":"Deep vein thrombosis in hospitalized patients with coronavirus disease 2019 (COVID-19) in Wuhan, China: prevalence, risk factors, and outcome","volume":"142","author":"Zhang","year":"2020","journal-title":"Circulation"},{"key":"R10-20250620","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/jth.14810","article-title":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19","volume":"18","author":"Thachil","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R11-20250620","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/rth2.12372","article-title":"A proposal for staging COVID-19 coagulopathy","volume":"4","author":"Thachil","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"R12-20250620","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11239-020-02138-z","article-title":"Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum","volume":"50","author":"Barnes","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"R13-20250620","first-page":"167","article-title":"COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET)","volume":"18","author":"Marietta","year":"2020","journal-title":"Blood Transfus"},{"key":"R14-20250620","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1182\/blood.2020006000","article-title":"COVID-19 and its implications for thrombosis and anticoagulation","volume":"135","author":"Connors","year":"2020","journal-title":"Blood"},{"key":"R15-20250620","first-page":"3950","article-title":"COVID-19, microangiopathy, hemostatic activation, and complement","volume":"130","author":"Song","year":"2020","journal-title":"J Clin Invest"},{"key":"R16-20250620","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1182\/blood-2004-10-4089","article-title":"Transglutaminase-mediated oligomerization of the fibrin(ogen) \u03b1C domains promotes integrin-dependent cell adhesion and signaling","volume":"105","author":"Belkin","year":"2005","journal-title":"Blood"},{"key":"R17-20250620","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1080\/22221751.2020.1770129","article-title":"Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors","volume":"9","author":"Han","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"R18-20250620","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/jmv.26078","article-title":"COVID-19: consider IL-6 receptor antagonist for the therapy of cytokine storm syndrome in SARS-CoV-2 infected patients","volume":"92","author":"Chakraborty","year":"2020","journal-title":"J Med Virol"},{"key":"R19-20250620","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12967-020-02374-0","article-title":"Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage","volume":"18","author":"Liu","year":"2020","journal-title":"J Transl Med"},{"key":"R20-20250620","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R21-20250620","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/ATVBAHA.111.242859","article-title":"Neutrophil extracellular trap (NET) impact on deep vein thrombosis","volume":"32","author":"Fuchs","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R22-20250620","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3324\/haematol.2016.142471","article-title":"Propagation of thrombosis by neutrophils and extracellular nucleosome networks","volume":"102","author":"Pfeiler","year":"2017","journal-title":"Haematologica"},{"key":"R23-20250620","first-page":"e138999","article-title":"Neutrophil extracellular traps in covid19","volume":"5","author":"Zuo","year":"2020","journal-title":"JCI Insight"},{"key":"R24-20250620","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nm.2184","article-title":"Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases","volume":"16","author":"Massberg","year":"2010","journal-title":"Nat Med"},{"key":"R25-20250620","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl Res"},{"key":"R26-20250620","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaci.2020.05.006","article-title":"Complement activation in patients with COVID-19: a novel therapeutic target","volume":"146","author":"Cugno","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"R27-20250620","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/ndt\/gfaa093","article-title":"ADAM17 inhibition may exert a protective effect on COVID-19","volume":"35","author":"Palau","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"R28-20250620","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1152\/physrev.00013.2020","article-title":"Elevated plasmin(ogen) as a common risk factor for COVID-19 susceptibility","volume":"100","author":"Ji","year":"2020","journal-title":"Physiol Rev"},{"key":"R29-20250620","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1152\/physrev.00017.2020","article-title":"An ounce of prevention may prevent hospitalization","volume":"100","author":"Barker","year":"2020","journal-title":"Physiol Rev"},{"key":"R30-20250620","doi-asserted-by":"crossref","first-page":"102537","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease","volume":"19","author":"McGonagle","year":"2020","journal-title":"Autoimmun Rev"},{"key":"R31-20250620","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med"},{"key":"R32-20250620","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M20-2003","article-title":"Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study","volume":"173","author":"Wichmann","year":"2020","journal-title":"Ann Intern Med"},{"key":"R33-20250620","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/his.14160","article-title":"Pulmonary and systemic involvement of COVID-19 assessed by ultrasound-guided minimally invasive autopsy","volume":"77","author":"Nunes Duarte-Neto","year":"2020","journal-title":"Histopathology"},{"key":"R34-20250620","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1055\/s-0040-1713152","article-title":"Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research","volume":"120","author":"Bikdeli","year":"2020","journal-title":"Thromb Haemost"},{"key":"R35-20250620","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1161\/01.ATV.0000151647.14923.ec","article-title":"Statins and blood coagulation","volume":"25","author":"Undas","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R36-20250620","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1111\/jth.14898","article-title":"Heparin \u2013 an old drug with multiple potential targets in Covid-19 therapy","volume":"18","author":"Lindahl","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R37-20250620","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/1076029609338711","article-title":"Comparative anticoagulant and platelet modulatory effects of enoxaparin and sulodexide","volume":"15","author":"Adiguzel","year":"2009","journal-title":"Clin Appl Thromb Hemost"},{"key":"R38-20250620","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaci.2020.05.006","article-title":"Complement activation in patients with COVID-19: a novel therapeutic target","volume":"146","author":"Cugno","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"R39-20250620","doi-asserted-by":"crossref","first-page":"107587","DOI":"10.1016\/j.pharmthera.2020.107587","article-title":"Cathepsin l-selective inhibitors: a potentially promising treatment for COVID-19 patients","volume":"213","author":"Liu","year":"2020","journal-title":"Pharmacol Ther"},{"key":"R40-20250620","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/jth.14872","article-title":"Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19","volume":"18","author":"Whyte","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R41-20250620","doi-asserted-by":"crossref","first-page":"444","DOI":"10.21037\/atm.2017.08.23","article-title":"Nebulized anticoagulants in lung injury in critically ill patients-an updated systematic review of preclinical and clinical studies","volume":"5","author":"Juschten","year":"2017","journal-title":"Ann Transl Med"},{"key":"R42-20250620","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/qjmed\/hcaa121","article-title":"Plasminogen improves lung lesions and hypoxemia in patients with COVID-19","volume":"113","author":"Yuanyuan Wu","year":"2020","journal-title":"QJM"},{"key":"R43-20250620","first-page":"4040","article-title":"Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience","volume":"24","author":"Diurno","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R44-20250620","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4081\/monaldi.2020.1300","article-title":"COVID-19 and coagulative axis: review of emerging aspects in a novel disease","volume":"90","author":"Boccia","year":"2020","journal-title":"Monaldi Arch Chest Dis"},{"key":"R45-20250620","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/09537104.2020.1762852","article-title":"Platelet functions and activities as potential hematologic parameters related to coronavirus disease 2019 (Covid-19)","volume":"31","author":"Salamanna","year":"2020","journal-title":"Platelets"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MBC.0000000000000993","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T17:02:40Z","timestamp":1750438960000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MBC.0000000000000993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,11]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0000000000000993","relation":{},"ISSN":["0957-5235","1473-5733"],"issn-type":[{"type":"print","value":"0957-5235"},{"type":"electronic","value":"1473-5733"}],"subject":[],"published":{"date-parts":[[2021,3,11]]}}}